Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review

被引:33
|
作者
Hase, Isano [1 ,2 ]
Morimoto, Kozo [3 ]
Sakagami, Takuro [4 ]
Ishii, Yoshiki [2 ]
van Ingen, Jakko [5 ]
机构
[1] Utsunomiya Hosp, Natl Hosp Org, Dept Resp Med, 2160 Shimo Okamoto, Utsunomiya, Tochigi 3291193, Japan
[2] Dokkyo Med Univ, Dept Pulm Med & Clin Immunol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan
[3] Fukujuji Hosp, Japan AntiTB Assoc, Resp Dis Ctr, 3-1-24 Matsuyama, Kiyose, Tokyo 2040022, Japan
[4] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan
[5] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands
关键词
Anti-interferon-gamma autoantibody; Nontuberculous mycobacterium; Clinical manifestation; Ethnicity; Adult-onset immunodeficiency; ADULT-ONSET IMMUNODEFICIENCY; AVIUM COMPLEX INFECTION; ACQUIRED-IMMUNODEFICIENCY; MENDELIAN SUSCEPTIBILITY; RECURRENT; TOXOPLASMOSIS; RITUXIMAB; DIAGNOSIS;
D O I
10.1016/j.diagmicrobio.2017.05.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nontuberculous mycobacteria (NTM) infections involving anti-interferon-gamma(IFN-gamma)-neutralizing auto antibodies have been described in previously immunocompetent adults. To investigate the factors underlying various disease manifestations, we reviewed 35 articles published between January 2004 and November 2016 and identified 111 NTM patients with anti-IFN-gamma, autoantibodies. Rapidly growing mycobacteria (RGM) accounted for 53% of the isolated species. RGM were predominant among the NTM species isolated from Thai (73%), Chinese (58%) and Filipino (56%) patients, whereas M. avium complex (MAC) was predominant among Japanese (58%) and non-Asian (80%) patients. The commonly involved organs included the lymph nodes (79%), bones/joints (34%) and lungs (32%). Compared with the patients with MAC, the patients with RGM had a higher incidence of lymph node lesions (P < 0.05) and a lower incidence of bone/joint (P < 0.01), lung (P < 0.01), soft tissue (P < 0.01), bronchus (P < 0.01) and muscle (P < 0.05) lesions. Clinical manifestations of NTM disease with anti-IFN-gamma-neutralizing autoantibodies differ across ethnicities and NTM species. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 38 条
  • [1] Natural History of Anti-Interferon-gamma Autoantibody-associated Immunodeficiency Syndrome in Thailand
    Hong, Gloria H.
    Chetchotisakd, Ploenchan
    Anunnatsiri, Siriluck
    Mootsikapun, Piroon
    Rosen, Lindsey B.
    Zerbe, Christa S.
    Holland, Steven M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 : S51 - S51
  • [2] THE MANAGEMENT OF ANTI-INTERFERON-GAMMA AUTOANTIBODY ASSOCIATED IMMUNODEFICIENCY SYNDROME IN A FEMALE WITH RECURRENT MYCOBACTERIAL DISEASE
    Cerrone, D.
    Ahn, T.
    Tsai, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S91 - S92
  • [3] Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome
    Angkasekwinai, Nasikarn
    Suputtamongkol, Yupin
    Tantibhedhyangkul, Wiwit
    Onlamoon, Nattawat
    Phoompoung, Pakpoom
    Pithukpakorn, Manop
    Karuphong, Ekkapun
    Pusuwan, Pawana
    Angkasekwinai, Pornpimon
    CLINICAL INFECTIOUS DISEASES, 2023, : 1033 - 1042
  • [4] Adult-onset immunodeficiency due to anti-interferon-gamma autoantibody-associated Sweet syndrome: A distinctive entity
    Kiratikanon, Salin
    Phinyo, Phichayut
    Rujiwetpongstorn, Rujira
    Patumanond, Jayanton
    Tungphaisal, Veeraphol
    Mahanupab, Pongsak
    Chaiwarith, Romanee
    Tovanabutra, Napatra
    Chiewchanvit, Siri
    Chuamanochan, Mati
    JOURNAL OF DERMATOLOGY, 2022, 49 (01): : 133 - 141
  • [5] Rituximab Treatment in Two Patients with Anti-Interferon Gamma Autoantibody-Associated Disseminated Mycobacterial Infections
    Bosco, J. J.
    Nicholls, K.
    McComish, J.
    Bleasel, K.
    Unglik, G.
    Choo, S.
    Flanagan, K.
    Fulcher, D. A.
    Naselli, G.
    Martinuzzi, E.
    Holland, S. M.
    Browne, S. K.
    Harrison, L. C.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S277 - S277
  • [7] Anti-interferon-gamma autoantibody and salmonellosis: Case report and literature review
    Towachiraporn, Saikhuan
    Thongwitokomarn, Harit
    Salee, Parichat
    IDCASES, 2024, 35
  • [8] Difference of affected organs between patients with and without anti-Interferon-gamma neutralizing autoantibodies in disseminated nontuberculous mycobacterial disease
    Kimura, Toshiki
    Imamura, Kosuke
    Tomita, Yusuke
    Ichiyasu, Hidenori
    Sakagami, Takuro
    RESPIROLOGY, 2023, 28 : 209 - 210
  • [9] Mycobacterial lymphadenitis without granuloma formation in a patient with anti-interferon-gamma antibodies
    Mizuki Asako
    Hitomi Matsunaga
    Wataru Nakahara
    Mako Ikeda
    Fuka Mima
    Ryota Minami
    Masahiro Sekiguchi
    Kazumasa Oka
    Naoki Wada
    Katsuhiro Suzuki
    Kazutaka Yoshizawa
    Takuro Sakagami
    Shuji Ueda
    International Journal of Hematology, 2021, 114 : 630 - 635
  • [10] Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection
    Browne, Sarah K.
    Zaman, Rifat
    Sampaio, Elizabeth P.
    Jutivorakool, Kamonwan
    Rosen, Lindsey B.
    Ding, Li
    Pancholi, Minjal J.
    Yang, Lauren M.
    Priel, Debra Long
    Uzel, Gulbu
    Freeman, Alexandra F.
    Hayes, Carlton E.
    Baxter, Roger
    Cohen, Stuart H.
    Holland, Steven M.
    BLOOD, 2012, 119 (17) : 3933 - 3939